Wednesday brought a fresh batch of analyst updates across Wall Street, with firms recalibrating their views on companies spanning apparel, industrial equipment, financial services, and energy. Here's the rundown of 10 notable rating changes that caught the market's attention.
Keybanc analyst Ashley Owens raised the price target on G-III Apparel Group, Ltd. (GIII) from $33 to $35, maintaining an Overweight rating. The apparel company's shares closed at $30.82 on Tuesday, suggesting the analyst sees further room to run.
In a more decisive move, Jefferies analyst Saree Boroditsky upgraded The Middleby Corporation (MIDD) from Hold to Buy while simultaneously boosting the price target from $130 to $175. That represents substantial upside from Tuesday's closing price of $129.00, signaling renewed confidence in the commercial kitchen equipment manufacturer.
Not all updates pointed higher. Keefe, Bruyette & Woods analyst Sanjay Sakhrani trimmed the price target on SLM Corporation (SLM) from $31 to $29, though he maintained a Market Perform rating. The student loan company's shares closed at $26.24 on Tuesday.
GE Vernova Inc. (GEV) received an increased price target from Susquehanna analyst Charles Minervino, who raised his target from $750 to $775 while maintaining a Positive rating. The energy equipment spinoff closed at $625.30 on Tuesday, suggesting analysts see considerable upside ahead.
Stifel analyst Parker Lane bumped up the price target for Braze, Inc. (BRZE) from $40 to $45, maintaining a Buy rating on the customer engagement platform. Braze shares closed at $30.65 on Tuesday.
Bernstein analyst Alexia Howard cut The Campbell's Company (CPB) price target from $39 to $33, though she maintained an Outperform rating. The soup and snacks maker settled at $28.47 on Tuesday, already trading below the new target.
BMO Capital analyst Tristan Thomas-Martin reduced the price target on AutoZone, Inc. (AZO) from $4,600 to $4,400 while keeping an Outperform rating. The auto parts retailer closed at $3,496.77 on Tuesday, still well below even the reduced target.
HC Wainwright & Co. analyst Robert Burns raised the price target for Nurix Therapeutics, Inc. (NRIX) from $28 to $31, maintaining a Buy rating. The biotech company's shares closed at $19.55 on Tuesday.
In the energy sector, Morgan Stanley analyst Devin McDermott increased the price target for Exxon Mobil Corporation (XOM) from $135 to $137, maintaining an Overweight rating. With Exxon shares settling at $118.25 on Tuesday, that implies potential upside of more than 15%, which explains the headline-grabbing attention.
Rounding out the list, Jefferies analyst Christopher LeFemina upgraded Commercial Metals Company (CMC) from Hold to Buy and raised the price target from $70 to $78. The steel and metals manufacturer closed at $66.18 on Tuesday.
These analyst moves reflect shifting views on everything from consumer staples to industrial plays, with the upgrades at Middleby and Commercial Metals particularly notable as they signal analysts moving from neutral to bullish stances. Meanwhile, the Exxon Mobil price target increase underscores continued optimism about the energy giant's prospects, even as oil markets navigate uncertainty.
